✦ LIBER ✦

130 The indications for LHRH treatment in men with prostate cancer

✍ Scribed by P. Blood; C. Paul; G. Steinhoff; J. Bamett; J. Spinelli; T. Pickles

Book ID: 119516831
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 117 KB
Volume: 76
Category: Article
ISSN: 0167-8140
DOI: 10.1016/s0167-8140(05)80291-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

20 The Duration of LHRH Treatment in Men

20 The Duration of LHRH Treatment in Men Receiving Radical Radiotherapy for Prostate Cancer

✍ P. Blood; C. Paulz; J. Barnett; J. Spinelli; T. Pickles; G. Steinhoff 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 236 KB

Long-term treatment with the LHRH-agonis

Long-term treatment with the LHRH-agonist buserelin in metastatic prostatic cancer

✍ Schröder, F.H.; Debruyne, F.J.M.; de Voogt, H.J.; Klijn, J.G.; de Jong, F.H. 📂 Article 📅 1986 🏛 Elsevier Science ⚖ 139 KB

Nanoparticulate delivery of LHRH analogu

Nanoparticulate delivery of LHRH analogue for the treatment of prostate cancer

✍ Tomar, Priti; Jain, Neeti; Dixit, Vinod Kumar 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 1004 KB

Treatment-related osteoporosis in men wi

✍ Maryanne Kazanis; Matthew R. Smith 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 76 KB

An open-label study of abarelix in men w

An open-label study of abarelix in men with symptomatic prostate cancer at risk of treatment with LHRH agonists

✍ Michael Koch; Christopher Steidle; Stanley Brosman; Arthur Centeno; Franklin Gay 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 121 KB

AFRICAN AMERICAN MEN HAVE LOWER RATE OF

AFRICAN AMERICAN MEN HAVE LOWER RATE OF TREATMENT FAILURE ON PRIMARY LHRH AGONIST THERAPY FOR PROSTATE CANCER

✍ Sassani, Pejvak; Blumberg, Jeremy M; Cheetham, Craig T; Niu, Fang; Jacobsen, Ste 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 61 KB